Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

FATE THERAPEUTICS INC Director's Dealing 2016

May 18, 2016

34091_dirs_2016-05-18_ef3d585b-30a2-42cc-b7c1-ab868df26b92.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-05-16

Reporting Person: Storgard Chris (Chief Medical Officer)

More from FATE THERAPEUTICS INC

Interim / Quarterly Report 2026
May 13
Regulatory Filings 2026
May 13
Proxy Solicitation & Information Statement 2026
Apr 24
Annual Report 2026
Feb 26
Regulatory Filings 2026
Feb 26
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 12
Director's Dealing 2026
Jan 12
View all filings →